NEW YORK STATE COMMON RETIREMENT FUND - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 191 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$260
+14.0%
45,542
+0.0%
0.00%
Q1 2024$228
-47.9%
45,526
-6.6%
0.00%
-100.0%
Q4 2023$438
+3.8%
48,722
-10.2%
0.00%0.0%
Q3 2023$422
-4.1%
54,269
+19.4%
0.00%0.0%
Q2 2023$440
-43.7%
45,463
-36.2%
0.00%0.0%
Q1 2023$781
+91.9%
71,265
-24.3%
0.00%0.0%
Q4 2022$407
-99.9%
94,198
-0.0%
0.00%0.0%
Q3 2022$708,000
-24.3%
94,200
+1.3%
0.00%0.0%
Q2 2022$935,000
+459.9%
93,000
+241.5%
0.00%
Q2 2017$167,000
-16.5%
27,234
-0.0%
0.00%
Q1 2017$200,00027,2350.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 188,500$4,311,0003.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 334,500$7,647,0001.70%
IRONWOOD INVESTMENT MANAGEMENT LLC 131,760$3,013,0001.49%
NEA Management Company, LLC 3,069,834$70,207,0001.42%
Berry Street Capital Management LLP 575,000$13,151,0001.36%
Melqart Asset Management (UK) Ltd 916,321$20,956,0001.06%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$2,287,0000.93%
HighMark Wealth Management LLC 50,499$1,155,0000.73%
Artal Group S.A. 1,000,000$22,870,0000.62%
Vigilare Wealth Management 34,925$799,0000.47%
View complete list of AURINIA PHARMACEUTICALS INC shareholders